SETTLE successfully represented a leading international pharmaceutical company in protecting its intellectual property (IP) rights against the unauthorized use of a trademark and the large-scale importation of counterfeit products. This case highlights SETTLE’s ability to combine litigation, enforcement, and strategic advisory work to combat counterfeiting in one of Uzbekistan’s most sensitive and highly regulated sectors.
Comprehensive Legal Support Against fake pharmaceuticals
The client faced a significant challenge when counterfeit drugs bearing similar designations to its registered trademark entered the Uzbek market. These products not only infringed upon the client’s IP rights but also posed risks to consumer health and caused commercial harm by diverting sales to lower-priced, unauthorized goods. SETTLE’s legal team provided end-to-end support, from monitoring and investigation to direct engagement with courts and law enforcement authorities.
Overcoming Enforcement Challenges in the Pharmaceutical Sector
Counterfeit pharmaceuticals often present unique enforcement challenges due to their widespread distribution networks and the difficulty of distinguishing them from authentic products. SETTLE attorneys proactively initiated pre-trial negotiations, collaborated with with courts and law enforcement, and spearheaded thorough monitoring and investigations. Through coordinated efforts, the team secured judicial and regulatory intervention to halt both the importation and distribution of counterfeit drugs in Uzbekistan.
Delivering Results Through Strong IP Enforcement
As a direct result of SETTLE’s representation, all identified counterfeit stocks were seized and destroyed. This decisive action not only eliminated the immediate threat to consumers but also restored the client’s market position and prevented further erosion of its brand value. The firm’s strategy demonstrated that robust IP enforcement can serve both legal and commercial objectives in protecting the pharmaceutical industry.